221 related articles for article (PubMed ID: 9361377)
21. Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.
Kamruzzaman SM; Endale M; Oh WJ; Park SC; Kim TH; Lee IK; Cho JY; Park HJ; Kim SK; Yun BS; Rhee MH
Phytother Res; 2011 Nov; 25(11):1596-603. PubMed ID: 21394810
[TBL] [Abstract][Full Text] [Related]
22. Thrombin-induced conversion of fibrinogen to fibrin results in rapid platelet trapping which is not dependent on platelet activation or GPIb.
Jarvis GE; Atkinson BT; Frampton J; Watson SP
Br J Pharmacol; 2003 Feb; 138(4):574-83. PubMed ID: 12598411
[TBL] [Abstract][Full Text] [Related]
23. Influence of direct thrombin inhibitor argatroban on coagulation assays in healthy individuals, patients under oral anticoagulation therapy and patients with liver dysfunction.
Siegmund R; Boer K; Poeschel K; Wolf G; Deufel T; Kiehntopf M
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):288-93. PubMed ID: 18469550
[TBL] [Abstract][Full Text] [Related]
24. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy.
Moshfegh K; Redondo M; Julmy F; Wuillemin WA; Gebauer MU; Haeberli A; Meyer BJ
J Am Coll Cardiol; 2000 Sep; 36(3):699-705. PubMed ID: 10987587
[TBL] [Abstract][Full Text] [Related]
25. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
26. Platelet aggregation through prothrombinase activation induced by non-aggregant doses of platelet agonists.
Corral J; González-Conejero R; Martínez C; Rivera J; Lozano ML; Vicente V
Blood Coagul Fibrinolysis; 2002 Mar; 13(2):95-103. PubMed ID: 11914651
[TBL] [Abstract][Full Text] [Related]
27. Modulation of thrombin-induced platelet aggregation by inhibition of calpain by a synthetic peptide derived from the thiol-protease inhibitory sequence of kininogens and S-(3-nitro-2-pyridinesulfenyl)-cysteine.
Puri RN; Matsueda R; Umeyama H; Bradford HN; Colman RW
Eur J Biochem; 1993 May; 214(1):233-41. PubMed ID: 8389701
[TBL] [Abstract][Full Text] [Related]
28. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
[TBL] [Abstract][Full Text] [Related]
29. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048
[TBL] [Abstract][Full Text] [Related]
30. Glycoprotein IIb/IIIa inhibitors increase COAT-platelet production in vitro.
Hamilton SF; Miller MW; Thompson CA; Dale GL
J Lab Clin Med; 2004 May; 143(5):320-6. PubMed ID: 15122176
[TBL] [Abstract][Full Text] [Related]
31. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
32. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide.
Rendu F; Bachelot C; Molle D; Caen J; Guez D
J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063
[TBL] [Abstract][Full Text] [Related]
33. Surfactin C inhibits platelet aggregation.
Kim SD; Park SK; Cho JY; Park HJ; Lim JH; Yun HI; Park SC; Lee KY; Kim SK; Rhee MH
J Pharm Pharmacol; 2006 Jun; 58(6):867-70. PubMed ID: 16734989
[TBL] [Abstract][Full Text] [Related]
34. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
[TBL] [Abstract][Full Text] [Related]
35. Effect of SR121566A, a potent GP IIb-IIIa antagonist on platelet-mediated thrombin generation in vitro and in vivo.
Herault JP; Peyrou V; Savi P; Bernat A; Herbert JM
Thromb Haemost; 1998 Feb; 79(2):383-8. PubMed ID: 9493595
[TBL] [Abstract][Full Text] [Related]
36. Novel antithrombotic drugs in development.
Verstraete M; Zoldhelyi P
Drugs; 1995 Jun; 49(6):856-84. PubMed ID: 7641602
[TBL] [Abstract][Full Text] [Related]
37. Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling.
Khamrang T; Hung KC; Hsia CH; Hsieh CY; Velusamy M; Jayakumar T; Sheu JR
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28448438
[TBL] [Abstract][Full Text] [Related]
38. On the mechanism of the spermine-exerted inhibition on alpha-thrombin-induced platelet activation.
Via LD; Francesconi M; Mazzucato M; Pradella P; De Marco L; Vecchia FD; Rascio N; Deana R
Thromb Res; 2000 Apr; 98(1):59-71. PubMed ID: 10706934
[TBL] [Abstract][Full Text] [Related]
39. A selective serotonin reuptake inhibitor, citalopram, inhibits collagen-induced platelet aggregation and activation.
Tseng YL; Chiang ML; Huang TF; Su KP; Lane HY; Lai YC
Thromb Res; 2010 Dec; 126(6):517-23. PubMed ID: 20961601
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of collagen-induced platelet activation by arachidonyl trifluoromethyl ketone.
McNicol A; Nickolaychuk BR
Biochem Pharmacol; 1995 Nov; 50(11):1795-802. PubMed ID: 8615857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
